Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012

Pediatric Infectious Disease Journal

Volumn 34, Issue 1, 2015, Pages 27-34

  Von Mollendorf, Claire ^a,b   Cohen, Cheryl ^a,b   De Gouveia, Linda ^a   Naidoo, Nireshni ^a,b   Meiring, Susan ^a   Quan, Vanessa ^a   Lindani, Sonwabo ^a   Moore, David P ^c,d   Reubenson, Gary ^e   Moshe, Mamokgethi ^f   Eley, Brian ^g   Hallbauer, Ute M ^h   Finlayson, Heather ⁱ   Madhi, Shabir A ^a,c,d   Conklin, Laura ^j   Zell, Elizabeth R ^j   Klugman, Keith P ^d,k   Whitney, Cynthia G ^j   Von Gottberg, Anne ^a,d  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c NATIONAL RESEARCH FOUNDATION   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

^h UNIVERSITY OF THE FREE STATE   (South Africa)

ⁱ STELLENBOSCH UNIVERSITY   (South Africa)

^j CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^k EMORY UNIVERSITY   (United States)

more..

Author keywords

Children; HIV; HIV exposure; Pneumococcal conjugate vaccine; Pneumococcus; Risk factors; South Africa

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

AGE; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; BLACK PERSON; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DRUG USE; FEMALE; HOSPITAL ADMISSION; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEDICAL HISTORY; PERINATAL PERIOD; PNEUMOCOCCAL INFECTION; POVERTY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SIBLING; SOUTH AFRICA; TUBERCULOSIS; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; BACTEREMIA; HEALTH STATUS; HIV INFECTIONS; INFANT; MENINGITIS, BACTERIAL; NEWBORN; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; PREVALENCE; SOCIOECONOMICS; UTILIZATION;

BACTEREMIA; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; HEALTH STATUS; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, BACTERIAL; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; SOUTH AFRICA; VACCINATION;

EID: 84940237702     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000484     Document Type: Article

References (34)

1. World Health Organization, UNICEF. Global immunization data. 2013. Available at: http://www.who.int/immunization-monitoring/Global-Immunization-Data-v2.pdf. Accessed August 8, 2013.
2. Madhi SA, Petersen K, Madhi A, et al. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis. 2000;31:170-176.
3. Goga AE, Dinh TH, Jackson DJ, for the SAPMTCTE Study Group. Evaluation of the effectiveness of the National Prevention of Mother-to-Child Transmission (PMTCT) programme on infant HIV measured at six weeks postpartum in South Africa 2010. Available at: http://www.health. gov. za/docs/reports/2012/pmtcteffectiveness.pdf. Accessed September 9, 2013. South African Medical Research Council, National Department of Health of South Africa and PEPFAR/US Centers for Disease Control and Prevention. 2012.
4. National Department of Health Communiqué. Effectiveness of the National Prevention of Mother-to-Child Transmission (PMTCT) programme in South Africa: 2011 National SAPMTCT survey results. 2012. Available at: http://www.mrc.ac.za/healthsystems/SAPMTCTEExecSummary2012.pdf. Accessed September 9, 2013.
5. Mussi-Pinhata MM, Motta F, Freimanis-Hance L, et al.; NISDI Perinatal Study Group. Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants. Int J Infect Dis. 2010;14(suppl 3):e176-e182.
6. Slogrove A, Reikie B, Naidoo S, et al. HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life. J Trop Pediatr. 2012;58:505-508.
7. Mussi-Pinhata MM, Freimanis L, Yamamoto AY, et al.; National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study Group. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries. Pediatrics. 2007;119:e694-e704.
8. Wang SA, Mantel CF, Gacic-Dobo M, et al. Progress in introduction of pneumococcal conjugate vaccine-worldwide, 2000-2012. MMWR Morb Mortal Wkly Rep. 2013 April 26;62:308-311.
9. Pilishvili T, Zell ER, Farley MM, et al. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pediatrics. 2010;126:e9-e17.
10. Levine OS, Farley M, Harrison LH, et al. Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics. 1999;103:E28.
11. O'Dempsey TJ, McArdle TF, Morris J, et al. A study of risk factors for pneumococcal disease among children in a rural area of west Africa. Int J Epidemiol. 1996;25:885-893.
12. Cohen C, von Mollendorf C, de Gouveia L, et al. Effectiveness of sevenvalent pneumococcal conjugate vaccine (PCV-7) against invasive pneumococcal disease in HIV-infected and -uninfected children in South Africa: a matched case-control study. Clin Infect Dis. 2014;58:3293-3305.
13. World Health Organization. WHO child growth standards and the identification of severe malnutrition in infants and children. 2009. Available at: http://www.who.int/nutrition/publications/severemalnutrition/9789241598163-eng.pdf. Accessed August 9, 2013. World Health Organisation, United Nations Children's Fund.
14. Ruoff KL, Whiley RA, Beighton D. Streptococcus. In: Murray PR, Baron EJ, Jorgensen JH, et al., eds. Manual of Clinical Microbiology. Washington, DC: ASM Press, 2006:405-421.
15. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2010. Report No.: CLSI document M100-S20.
16. World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2007. Available at: http://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf. Accessed July 11, 2013.
17. Moore DP, Klugman KP, Madhi SA. Role of Streptococcus pneumoniae in hospitalization for acute community-acquired pneumonia associated with culture-confirmed Mycobacterium tuberculosis in children: a pneumococcal conjugate vaccine probe study. Pediatr Infect Dis J. 2010;29:1099-1104.
18. Dworkin MS, Ward JW, Hanson DL, et al.; Adult and Adolescent Spectrum of HIV Disease Project. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis. 2001;32:794-800.
19. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2013. Available at: http://apps.who.int/iris/bits tream/10665/85321/1/9789241505727-eng.pdf. Accessed July 11, 2013.
20. Farley JJ, King JC Jr, Nair P, et al. Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infection. J Pediatr. 1994;124:853-858.
21. de Moraes-Pinto MI, Almeida AC, Kenj G, et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis. 1996;173:1077-1084.
22. McNally LM, Jeena PM, Gajee K, et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet. 2007;369:1440-1451.
23. Filteau S. The HIV-exposed, uninfected African child. Trop Med Int Health. 2009;14:276-287.
24. Madhi SA, Adrian P, Cotton MF, et al.; Comprehensive International Program of Research on AIDS 4 Study Team. Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants. J Infect Dis. 2010;202:355-361.
25. Abdullahi O, Karani A, Tigoi CC, et al. The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, Kenya. PLoS One. 2012;7:e30787.
26. Whitney CG, Pilishvili T, Farley MM, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet. 2006;368:1495-1502.
27. Melegaro A, Gay NJ, Medley GF. Estimating the transmission parameters of pneumococcal carriage in households. Epidemiol Infect. 2004;132:433-441.
28. Scott JA, Hall AJ, Dagan R, et al. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7, 000 episodes of invasive disease. Clin Infect Dis. 1996;22:973-981.
29. Klugman KP. Risk factors for antibiotic resistance in Streptococcus pneumoniae. S Afr Med J. 2007;97(11 pt 3):1129-1132.
30. Madhi SA, Klugman KP; Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med. 2004;10:811-813.
31. Kuster SP, Tuite AR, Kwong JC, et al.; Toronto Invasive Bacterial Diseases Network Investigators. Evaluation of coseasonality of influenza and invasive pneumococcal disease: results from prospective surveillance. PLoS Med. 2011;8:e1001042.
32. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19:571-582.
33. Talbot TR, Poehling KA, Hartert TV, et al. Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine. Pediatr Infect Dis J. 2004;23:726-731.
34. Hsu K, Pelton S, Karumuri S, et al.; Massachusetts Department of Public Health Epidemiologists. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Pediatr Infect Dis J. 2005;24:17-23.